Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02179333 · ClinicalTrials.gov registry record
Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND)
A clinical trial of Friedreich's Ataxia and Spinocerebellar Ataxia - All Sub-types, sponsored by University of South Florida.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT02179333 is a study of Friedreich's Ataxia and Spinocerebellar Ataxia - All Sub-types that has completed, run by University of South Florida. The registered enrollment target is 30 participants, below the 74-participant average among 5 other Friedreich's Ataxia trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02179333, a study of Friedreich's Ataxia and Spinocerebellar Ataxia - All Sub-types, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The objectives of this study are: * To validate the inter-rater and intra-rater reliability of a new scale for the assessment of ataxia and neurologic dysfunction (STAND) * To assess common constructs and correlation between STAND subscale items.
Conditions Studied
Interventions
- OTHER Ataxia rating scale
Study Locations (1)
Florida
- University of South Florida - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-10 |
| Est. Completion | 2016-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02179333
The ClinicalTrials.gov registry entry for NCT02179333 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 74-participant average among 5 other Friedreich's Ataxia trials with a reported enrollment target (59% lower). The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Friedreich's Ataxia appearing as the primary indexed condition, and to 1 intervention - of which Ataxia rating scale is the first listed.
NCT02179333 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02179333 about?
NCT02179333 is a clinical study titled "Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND)". The objectives of this study are: * To validate the inter-rater and intra-rater reliability of a new scale for the assessment of ataxia and neurologic dysfunction (STAND) * To assess common constructs and correlation between STAND subscale items.
What is the current status of trial NCT02179333?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2012-10. Estimated completion is 2016-06.
What conditions does trial NCT02179333 study?
This clinical trial studies the following conditions: Friedreich's Ataxia, Spinocerebellar Ataxia - All Sub-types.
What interventions are being tested in trial NCT02179333?
The interventions under investigation include: Ataxia rating scale (OTHER).
Who is sponsoring clinical trial NCT02179333?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02179333 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Friedreich's Ataxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Biomarkers in Friedreich's Ataxia
RECRUITING
-
Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)
RECRUITING
-
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
COMPLETED · Phase 1
-
EPI-743 in Friedreich's Ataxia Point Mutations
COMPLETED · Phase 2
-
A First in Human Study of RT001 in Patients With Friedreich's Ataxia
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.